Home » Topics » Disease categories and therapies » Immune

Immune
RSS

cDNA clones of tick-borne flavivirus available for licensing from NIH

Aug. 22, 2000

NIH offers V1 knockout mice for S. pneumoniae vaccine screening

Aug. 22, 2000

Peptide vaccines available for licensing from NIH

Aug. 22, 2000

Research associates synapsins with cyclosporine-induced hypertension

Aug. 21, 2000

NIH offers type I TNF receptor regulator for licensing

Aug. 17, 2000

Roche's CellCept approved for third organ rejection indication

Aug. 16, 2000

Chiron's Menjugate approved in Ireland

Aug. 10, 2000

New peptides under development at Ludwig Institute

Aug. 9, 2000

New IL-5 inhibitors under development at Janssen

Aug. 8, 2000

New TNF inhibitors under development at Daiichi

Aug. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...